Title:
｛［５−（３−クロロフェニル）−３−ヒドロキシピリジン−２−カルボニル］アミノ｝酢酸の新規結晶形及びその製造方法
Document Type and Number:
Japanese Patent JP2020500925
Kind Code:
A
Abstract:
本発明は｛［５−（３−クロロフェニル）−３−ヒドロキシピリジン−２−カルボニル］アミノ｝酢酸の新規結晶形及びその製造方法並びに用途に関する。本発明で得られた｛［５−（３−クロロフェニル）−３−ヒドロキシピリジン−２−カルボニル］アミノ｝酢酸の結晶形ＣＳ１、結晶形ＣＳ２、結晶形ＣＳ８は、貧血症治療薬の製剤製造に使用でき、｛［５−（３−クロロフェニル）−３−ヒドロキシピリジン−２−カルボニル］アミノ｝酢酸を含む医薬製剤の製造に新しい選択を提供し、医薬開発において非常に重要な価値を有する。
Inventors:
Chen, Minhua
Jahn, Janphen
Elephant, poe
Warn, Jin Chiu
Shaoyu
Jahn, Janphen
Elephant, poe
Warn, Jin Chiu
Shaoyu
Application Number:
JP2019531739A
Publication Date:
January 16, 2020
Filing Date:
December 13, 2017
Export Citation:
Assignee:
Crystal Pharmaceuticals (Sucho) Company, Limited
International Classes:
C07D213/81; A61K31/4418; A61P7/06
Domestic Patent References:
| JP2016537365A | 2016-12-01 | |||
| JP5113838B2 | 2013-01-09 | |||
| JP2014522409A | 2014-09-04 |
Foreign References:
| WO2016153996A1 | 2016-09-29 | |||
| CN105837502A | 2016-08-10 |
Other References:
芦澤 一英、他, 医薬品の多形現象と晶析の科学, JPN7016001492, 20 September 2002 (2002-09-20), pages 272 - 317, ISSN: 0004876799
BYRN S: "PHARMACEUTICAL SOLIDS: A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS", PHARMACEUTICAL RESEARCH, vol. V12 N7, JPN5013009960, 1 July 1995 (1995-07-01), US, pages 945 - 954, XP055307460, ISSN: 0004876800, DOI: 10.1023/A:1016241927429
PHARM TECH JAPAN, vol. 18, no. 10, JPN7014002019, 2002, pages 81 - 96, ISSN: 0004876801
BYRN S: "PHARMACEUTICAL SOLIDS: A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS", PHARMACEUTICAL RESEARCH, vol. V12 N7, JPN5013009960, 1 July 1995 (1995-07-01), US, pages 945 - 954, XP055307460, ISSN: 0004876800, DOI: 10.1023/A:1016241927429
PHARM TECH JAPAN, vol. 18, no. 10, JPN7014002019, 2002, pages 81 - 96, ISSN: 0004876801
Attorney, Agent or Firm:
Shinjiro Ono
Osamu Yamamoto
Toru Miyamae
Motoharu Nakanishi
Akiko Yamaguchi
Osamu Yamamoto
Toru Miyamae
Motoharu Nakanishi
Akiko Yamaguchi